The In Vitro Diagnostics Market in 2023 is US$ 121.38 billion, and is expected to reach US$ 176.89 billion by 2031 at a CAGR of 4.82%.
FutureWise Research published a report that analyzes In Vitro Diagnostics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This In Vitro Diagnostics research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for In Vitro Diagnostics Market Sample
In vitro Diagnostics Market Segmentation:
By Product and Services
· Reagents & Kits
· Instruments
· Fully-automated Instruments
· Semi-automated Instruments
· Others
· Data Management Software
· Services
By Technology
· Immunochemistry/Immunoassay
· Chemiluminescence Immunoassay (CLIA)
· Fluorescence Immunoassay (FIA)
· Colorimetric Immunoassay (CI)
· Radioimmunoassays (RIA)
· Rapid Tests
· Western Blot
· ELISPOT
· Clinical Chemistry
· Basic Metabolic Panel
· Electrolyte Panel
· Liver Panel
· Lipid Profile
· Renal Profile
· Thyroid Function Panel
· Specialty Chemicals
· Molecular Diagnostics
· Polymerase Chain Reaction (PCR)
· Isothermal Nucleic Acid Amplification Technology (INAAT)
· In-situ Hybridization
· DNA Microarrays
· Others
· Hemostasis
· Urinalysis
· Others
By Application
· Infectious Diseases
· Diabetes
· Drug Testing/Pharmacogenomics
· Autoimmune Diseases
· Oncology
· Cardiology
· HIV/AIDS
· Nephrology
· Other Applications
By End User
· Laboratories
· Large/Reference Laboratories
· Medium-sized Laboratories
· Small Laboratories
· Hospitals
· Academics
· Point-Of-Care Testing
· Patient Self-Testing
· Others
By Region
· North America
· Europe
· Asia Pacific
· Latin America
· Middle East and Africa
Major players included in In Vitro Diagnostics Market:
· Siemens Healthcare
· Abbott Laboratories
· Qiagen N.V.
· Thermo Fischer Scientific Inc
· F.Hoffmann-La Roche AG
· Danaher Corporation
· Sysmex Corporation
· Becton, Dickinson and Company
· Biomerieux SA
· Bio-rad Laboratories Inc
· Johnson and Johnson
· Agilent Technologies
